TY  - GEN
AU  - Enzinger,Peter C
AU  - Burtness,Barbara Ann
AU  - Niedzwiecki,Donna
AU  - Ye,Xing
AU  - Douglas,Kathe
AU  - Ilson,David H
AU  - Villaflor,Victoria Meucci
AU  - Cohen,Steven J
AU  - Mayer,Robert J
AU  - Venook,Alan
AU  - Benson,Al Bowen
AU  - Goldberg,Richard M
TI  - CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers
SN  - 1527-7755
PY  - 2017///0726
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Camptothecin
KW  - Carcinoma, Squamous Cell
KW  - Cetuximab
KW  - Cisplatin
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Epirubicin
KW  - Esophageal Neoplasms
KW  - Esophagogastric Junction
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Irinotecan
KW  - Leucovorin
KW  - Male
KW  - Middle Aged
KW  - Organoplatinum Compounds
KW  - Survival Rate
KW  - Time Factors
KW  - Treatment Failure
N1  - Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1200/JCO.2015.65.5092
ER  -